A team of clinical pharmacists at Atrium Health, in North Carolina, have begun a specialized anticoagulation clinic to reduce the high risk for primary or recurrent venous thromboembolism (VTE) in patients with gastrointestinal, genitourinary and other types of cancer.
So far, the program’s introduction has been smooth and underscores the power of a collaborative approach to managing these high-risk patients, according to Kristyn DiSogra, PharmD, BCOP, a clinical pharmacist coordinator at